Europe
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Despite a broader slowdown in US IP partner hiring in 2025, litigation demand drove aggressive lateral expansion at select firms
Sponsored
Sponsored
-
Sponsored by Bird & BirdSenior intellectual property practitioners of Bird & Bird consider the factors that are leading to a large number of filings to the Unified Patent Court being made by companies based outside Europe -
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Anja Fux of Maiwald discuss an EPO board ruling relating to the standard of disclosure concerning the novelty and sufficiency of a therapeutic effect in the context of existing case law
-
Sponsored by Gün and PartnersSelin Sinem Erciyas, Aysel Korkmaz Yatkin, and Fatma Sevde Tan of Gün and Partners consider whether a guarantee provided for a preliminary injunction is part of a later compensation action arising from an unfair preliminary injunction
-
Sponsored by CASMatt Garver and Peter Mattei of CAS discuss why companies should develop patent monitoring programmes
-
Sponsored by Bird & BirdJade Thompson of Bird & Bird IP Services, wholly owned by Bird & Bird LLP, discusses the importance of innovative approaches to legal services provision and whether legal tech is the only way forward
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos reviews a recent referral to the EPO Enlarged of Board of Appeal relating to the impact of statements in the description on the interpretation of claims
European Jurisdictions